CEACAM5 and non-small cell lung carcinoma: Another study published in 2020 showed that a combination of two plasma exosome-derived miRNAs (miR-320a and miR-622), with CEA and Cyfra21-1 markers, differentiate NSCLC patients with metastasis from those without metastasis with an AUC of 0.9.